IPI-145 in Relapsed Refractory Acute Lymphoblastic Leukemia (ALL)
Status:
Withdrawn
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
The goal of this clinical research study is to learn if IPI-145 can help to control the
disease in patients with ALL. The safety of the study drug will also be studied.